Profil
Mark Eisenberg has been a Director since 1991.
Dr. Eisenberg was formerly Senior Vice President and a consultant .
He has been a physician in private practice in Sydney, Australia since 1967.
He is a member and co-founder of the dystrophic epidermolysis bullosa clinic at the Prince of Wales Hospital for children in Sydney, Australia.
He has done extensive research on epidermolysis bullosa disease.
Steven Lilien has been a Director
Anciens postes connus de Mark Eisenberg
| Sociétés | Poste | Fin |
|---|---|---|
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Advances regenerative medicine through development of cellular technology & advanced biomaterial products | Directeur/Membre du Conseil | 21/06/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Advances regenerative medicine through development of cellular technology & advanced biomaterial products | Health Technology |
















